DCM

DAFNA Capital Management Portfolio holdings

AUM $362M
1-Year Return 0.48%
This Quarter Return
-9.11%
1 Year Return
-0.48%
3 Year Return
+117.01%
5 Year Return
+181.93%
10 Year Return
+1,483.26%
AUM
$377M
AUM Growth
-$101M
Cap. Flow
-$21.7M
Cap. Flow %
-5.76%
Top 10 Hldgs %
50.73%
Holding
91
New
7
Increased
20
Reduced
15
Closed
11

Top Buys

1
CYTK icon
Cytokinetics
CYTK
$6.26M
2
IDYA icon
IDEAYA Biosciences
IDYA
$3.27M
3
KRTX
Karuna Therapeutics, Inc. Common Stock
KRTX
$2.64M
4
ALEC icon
Alector
ALEC
$2.45M
5
KALV icon
KalVista Pharmaceuticals
KALV
$2.24M

Top Sells

1
TBPH icon
Theravance Biopharma
TBPH
$10.6M
2
TBIO
Translate Bio, Inc. Common Stock
TBIO
$10.4M
3
PRQR icon
ProQR Therapeutics
PRQR
$6.16M
4
LMNX
Luminex Corp
LMNX
$5.12M
5
TVRD
Tvardi Therapeutics, Inc. Common Stock
TVRD
$4.5M

Sector Composition

1 Healthcare 91.17%
Name Market Value Portfolio Weight Shares or Principal Shares
Change % 		Capital Flow
ANNX icon
76
Annexon
ANNX
$236M
$434K 0.12%
+23,296
New +$434K
RDUS
77
DELISTED
Radius Health, Inc.
RDUS
$180K 0.05%
14,500
– –
NTBL
78
DELISTED
Notable Labs, Ltd. Ordinary Shares
NTBL
$113K 0.03%
1,571
-7,200
-82% -$518K
APLS icon
79
Apellis Pharmaceuticals
APLS
$3.62B
– –
-12,703
Closed -$803K
ASND icon
80
Ascendis Pharma
ASND
$12B
– –
-7,137
Closed -$939K
CNTB
81
Connect Biopharma Holdings Limited Ordinary Shares
CNTB
$99.2M
– –
-8,000
Closed -$156K
RDHL
82
Redhill Biopharma
RDHL
$2.82M
– –
-456
Closed -$3.14M
SCPH icon
83
scPharmaceuticals
SCPH
$300M
– –
-38,891
Closed -$238K
TBPH icon
84
Theravance Biopharma
TBPH
$708M
– –
-732,345
Closed -$10.6M
TVRD
85
Tvardi Therapeutics, Inc. Common Stock
TVRD
$285M
– –
-8,750
Closed -$4.5M
CFMS
86
DELISTED
Conformis, Inc. Common Stock
CFMS
– –
-52,000
Closed -$1.5M
TBIO
87
DELISTED
Translate Bio, Inc. Common Stock
TBIO
– –
-376,993
Closed -$10.4M
LMNX
88
DELISTED
Luminex Corp
LMNX
– –
-139,091
Closed -$5.12M
ACRS icon
89
Aclaris Therapeutics
ACRS
$224M
– –
-100,000
Closed -$1.76M
1 2 3
4